Skip to main content
. 2021 Jul 6;16:9. doi: 10.1186/s12263-021-00691-7

Table 2.

Effect of transferrin concentration GWAS identified variants on breast cancer

SNPs Chr: BP (Build 37) Locus Effect/other allele Transferrin (μmol/L) Overall breast cancer ER-positive breast cancer ER-negative breast cancer
Betab (SE) P value Betac (SE) P value Betac (SE) P value Betac (SE) P value
rs744653 2: 190,378,750 WDR75–SLC40A1 T/C 0.068 (0.010) 1.35E−11 −0.009 (0.009) 0.3548 −0.007 (0.011) 0.500 −0.016 (0.016) 0.310
rs8177240 3: 133,477,701 TF T/G −0.380 (0.007) 8.43E−610 −0.014 (0.007) 0.039 −0.014 (0.008) 0.072 −0.012 (0.012) 0.304
rs9990333 3: 195,827,205 TFRC T/C −0.051 (0.007) 1.95E−13 −0.012 (0.007) 0.059 −0.015 (0.008) 0.062 −0.015 (0.012) 0.210
rs1800562a 6: 26,093,141 HFE A/G −0.479 (0.016) 8.90E−196 −0.003 (0.014) 0.831 0.010 (0.016) 0.535 −0.027 (0.025) 0.288
rs1799945a 6: 26,091,179 HFE C/G 0.114 (0.010) 9.36E−30 −0.001 (0.009) 0.913 −0.003 (0.011) 0.804 −0.014 (0.016) 0.380
rs4921915 8: 18,272,466 NAT2 A/G 0.079 (0.009) 7.05E−19 −0.010 (0.007) 0.187 −0.012 (0.009) 0.186 −0.014 (0.013) 0.295
rs174577 11: 61,604,814 FADS2 A/C 0.062 (0.007) 2.28E−17 −0.006 (0.007) 0.341 0.002 (0.008) 0.761 −0.033 (0.012) 0.007
rs6486121 11: 13,355,770 ARNTL T/C −0.046 (0.007) 3.89E−10 −0.004 (0.006) 0.587 −0.002 (0.007) 0.809 −0.009 (0.012) 0.450
rs855791a 22: 37,462,936 TMPRSS6 A/G 0.044 (0.007) 1.98E−09 −0.003 (0.006) 0.627 0.001 (0.008) 0.852 −0.013 (0.012) 0.255

a3 SNPs used in the conservative analyses. GWAS genome-wide association studies, SNPs single nucleotide polymorphisms, Chr chromosome, BP base pair, SE standard error, ER oestrogen receptor

bBeta units are per-allele effect estimates in transferrin concentrations

cPer-allele logarithm of the odds ratios between breast cancer cases and controls